Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 32 Sarcoma 29 Neoplasm Metastasis 17 Ovarian Neoplasms 10 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 6 Kidney Neoplasms 6 Recurrence 5 Lung Neoplasms 5 Liposarcoma 5 Thyroid Neoplasms 4 Melanoma 4 Leiomyosarcoma 4 Hemangiosarcoma 4 Urinary Bladder Neoplasms 3 Solid Tumors 3 Pancreatic Neoplasms 3 Neurofibrosarcoma 3 Glioblastoma 3 Gastrointestinal Stromal Tumors 3 Chondrosarcoma, Extraskeletal Myxoid 3 Advanced Cancers 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Fibrous Tumors 2 Small Cell Lung Carcinoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdomyosarcoma 2

Interventions

pazopanib 1 lenvatinib 1 Imatinib Mesylate 1 Coal Tar 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × GIST × pazopanib × Clear all

NCT01323400 2016-02-25

PAZOGIST

Centre Leon Berard

Phase 2 Completed

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡